Loading...
Back to narrative

DIVISLAB: Upcoming Board Meeting And Leadership Review Will Shape Fair Outlook

Custom Synthesis And Capacity Expansion Will Unlock Global Demand

DIVISLAB logo
DIVISLAB
AnalystConsensusTarget
Not Invested
Published 10 Nov 2024

Update shared on 11 Dec 2025

Previous
n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
Loading
1Y
9.6%
7D
-0.8%

Analysts have nudged their price target for Divi's Laboratories slightly higher, reflecting marginal improvements in discount rate assumptions and long term growth expectations that together support a fair value estimate of ₹6,785.10 per share.

What's in the News

  • Board meeting scheduled for November 7, 2025, at 10:30 IST to review unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025 (company filing).
  • Board to consider changes in senior management personnel at the same November 7, 2025 meeting, indicating a potential leadership reshuffle (company filing).

Valuation Changes

  • Fair Value Estimate remains unchanged at approximately ₹6,785 per share, indicating no material revision to the intrinsic value calculation.
  • The Discount Rate has fallen slightly from about 14.03 percent to 13.99 percent, reflecting a modestly lower perceived risk or cost of capital.
  • Revenue Growth is effectively unchanged at around 16.84 percent, implying stable long term topline growth expectations.
  • The Net Profit Margin is effectively unchanged at about 25.82 percent, suggesting no meaningful shift in long term profitability assumptions.
  • The Future P/E has eased slightly from roughly 64.57x to 64.50x, pointing to a marginally lower valuation multiple applied to forward earnings.

Have other thoughts on Divi's Laboratories?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.